Non-alcoholic fatty liver disease, obesity and other illnesses

Tarantino, Giovanni
October 2008
Clinical & Investigative Medicine;Oct2008, Vol. 31 Issue 5, pE290
Academic Journal
The estimated prevalence of NonAlcoholic Fatty Liver Disease in the general population in western countries is about 30%, but it is higher among obese and diabetic people. It is likely that more sophisticated approaches are required to understand its pathogenesis and to develop drug targets. In the meantime, the range of associations between NAFLD and other illnesses broadens. Although association does not mean causation, the link between some diseases and NAFLD suggests a common mechanism.


Related Articles

  • Non-alcoholic fatty liver disease in the Philippines: Comparable with other nations? Omagari, Katsuhisa; De Lusong, Mark Anthony A.; Labio, E.; Daez, L.; Gloria, V.; Wallace, Ian D. // World Journal of Gastroenterology;2/14/2008, Vol. 14 Issue 6, p913 

    AIM: To evaluate the prevalence and determined the common characteristics of patients diagnosed with non-alcoholic fatty liver disease (NAFLD) at the Philippine General Hospital, Manila, from January 1999 to December 2004. METHODS: NAFLD was diagnosed in 134 from a total of 1102 patients, based...

  • Advances in the Understanding and Treatment of Nonalcoholic Fatty Liver Disease. Harrison, Stephen A.; Di Bisceglie, Adrian M. // Drugs;2003, Vol. 63 Issue 22, p2379 

    Nonalcoholic fatty liver disease (NAFLD) is a well recognised form of chronic liver disease that has recently gained greater recognition. Originally described in the late 1950s, NAFLD is currently considered the leading cause of abnormal liver enzyme levels in the US, closely paralleling the...

  • Susceptibilidad genética a la cirrosis. Rojas, Isela Parra; López, Erika Martínez; Madrigal, Bertha Ruiz; Cerda, Arturo Panduro // Investigación en Salud;mar2005 Special, Issue 7, p48 

    Obesity and diabetes are common our population and are frequently associated with nonalcoholic fatty liver disease (NAFLD), which includes nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). Nonalcoholic fatty liver is usually considered bening, but nonalcoholic...

  • Current and Future Therapeutic Strategies in NAFLD. de Alwis, Nimantha Mark Wilfred; Day, Christopher Paul // Current Pharmaceutical Design;6/11/2010, Vol. 16 Issue 17, p1958 

    Non alcoholic fatty liver disease (NAFLD) is increasingly diagnosed worldwide and considered to be the commonest liver disorder in Western countries. It comprises a disease spectrum ranging from simple steatosis (fatty liver), through non-alcoholic steatohepatitis (NASH) to fat with fibrosis and...

  • Glucose Intolerance and the Amount of Visceral Adipose Tissue Contribute to an Increase in Circulating Triglyceride Concentrations in Caucasian Obese Females. Berings, Margot; Wehlou, Charline; Verrijken, An; Deschepper, Ellen; Mertens, Ilse; Kaufman, Jean-Marc; Van Gaal, Luc F.; Ouwens, D. Margriet; Ruige, Johannes B.; Atkin, Stephen L. // PLoS ONE;Sep2012, Vol. 7 Issue 9, Special section p1 

    Context: Lipotoxicity is a risk factor for developing obesity-related metabolic complications, including non-alcoholic fatty liver disease, type 2 diabetes (DM2), cardiovascular disease and stroke. Yet, the mechanisms underlying the development of lipotoxicity itself remain poorly understood....

  • Retinol-Binding Protein 4 and New Adipocytokines in Nonalcoholic Fatty Liver Disease. T�njes, Anke; Bl�her, Matthias; Stumvoll, Michael // Current Pharmaceutical Design;6/11/2010, Vol. 16 Issue 17, p1921 

    Nonalcoholic fatty liver disease (NAFLD) is one of the most prevalent causes of hepatic dysfunction and is highly correlated with components of the metabolic syndrome such as obesity, insulin resistance and type 2 diabetes. Among others, nutritional factors, physical inactivity, genetic variants...

  • Paediatric non-alcoholic fatty liver disease. Nobili, Valerio; Pinzani, Massimo // Gut;May2010, Vol. 59 Issue 5, p561 

    The article discusses the non-alcoholic fatty liver disease (NAFLD) in children. It mentions that NAFLD has become the common liver disease in children as well as adolescents due to overweight and obesity during their childhood. It states that NAFLD is associated with type 2 diabetes mellitus....

  • Pathology of Nonalcoholic Fatty Liver Disease. Matthew Yeh; Elizabeth Brunt // American Journal of Clinical Pathology;Nov2007, Vol. 128 Issue 5, p837 

    Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are gaining increasing recognition as components of the emerging epidemic of obesity in North America and in other parts of the world. These entities are considered the hepatic manifestations of the insulin...

  • Serum TAG Analysis Differentiates Between Genetic and Obesity-Associated NAFLD. Mashek, Douglas G.; Greenberg, Andrew S. // Diabetes;Jan2014, Vol. 63 Issue 1, p42 

    The article discusses the results of the study "Circulating Triacylglycerol Signatures in Nonalcoholic Fatty Liver Disease Associated With the l148M Variant in PNPLA3 and With Obesity," by J. Hyysalo, P. Gopalacharyulu, H. Bian and colleagues, published within the issue. Findings show that...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics